PTC Therapeutics elevates biotech buyout CEO to chief development officer

Late last year, PTC Therapeutics bought up California-based BioElectron Technology in a small deal, nabbing its leading drug, EPI-743, for metabolic and mitochondrial disorders.

PTC Therapeutics elevates biotech buyout CEO to chief development officer
Late last year, PTC Therapeutics bought up California-based BioElectron Technology in a small deal, nabbing its leading drug, EPI-743, for metabolic and mitochondrial disorders.